Effects of bisaramil, a novel class I antiarrhythmic agent, on heart, skeletal muscle and brain NA+ channels

European Journal of Pharmacology

Volumn 342, Issue 1, 1998, Pages 93-104

  Pugsley, Michael K ^a   Goldin, Alan L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Antiarrhythmic class I; Bisaramil; Lidocaine; Na+ channel; Xenopus oocyte

Indexed keywords

ANTIARRHYTHMIC AGENT; BISARAMIL; LIDOCAINE; SODIUM CHANNEL; SODIUM ION;

ANIMAL CELL; ANTIARRHYTHMIC ACTIVITY; ARTICLE; BRAIN; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENCY; HEART MUSCLE; NONHUMAN; OOCYTE; PRIORITY JOURNAL; SKELETAL MUSCLE; SODIUM CURRENT; VOLTAGE CLAMP; XENOPUS LAEVIS;

ANESTHETICS, LOCAL; ANIMALS; ANTI-ARRHYTHMIA AGENTS; BICYCLO COMPOUNDS, HETEROCYCLIC; BRAIN CHEMISTRY; ELECTROPHYSIOLOGY; HEART; LIDOCAINE; MUSCLE, SKELETAL; MYOCARDIUM; OOCYTES; RATS; SODIUM CHANNEL BLOCKERS; SODIUM CHANNELS; TRANSCRIPTION, GENETIC; XENOPUS;

EID: 0032545731     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)01420-9     Document Type: Article

References (39)

1. Alpert L.A., Fozzard H.A., Hanck D.A., Makielski J.C. Is there a second external lidocaine binding site on mammalian cardiac cells? Am. J. Physiol. 257:1989;H79.
2. + channel. Proc. Natl. Acad. Sci. USA. 87:1990;323.
3. + channels. J. Gen. Physiol. 81:1983;613.
4. + channels. Modification of block by alterations in the α-subunit III-IV interdomain. Circ. Res. 77:1995;584.
5. Cascio W.E., Johnson T.A., Gettes L.S. Electrophysiologic changes in ischemic ventricular myocardium: I. Influence of ionic, metabolic, and energetic changes. J. Cardiovasc. Electrophysiol. 6:1995;1039.
6. + channel block by lidocaine in isolated cardiac myocytes. Circ. Res. 63:1988;869.
7. + channels by tetrodotoxin. J. Mol. Cell. Cardiol. 20:1988;1119.
8. + channel inactivation. In: Perracjia, C. (Ed.), Handbook of Membrane Channels, Vol.1, Academic Press, San Diego, CA, p. 121.
9. + channels. In: North, R.A. (Ed.), Ligand- and Voltage-Gated Ion Channels, CRC Press, Boca Raton, FL, p. 73.
10. Goldin A.L., Sumikawa K. Preparation of RNA for injection into Xenopus oocytes. Methods Enzymol. 207:1992;279.
11. Haruno A., Hashimoto K. Antiarrhythmic effects of bisaramil on triggered arrhythmias produced by intracoronary injection of digitalis and adrenaline in the dog. Jpn. J. Pharmacol. 68:1995;95.
12. Hille B. Local anesthetics: hydrophilic and hydrophobic pathways for the drug-receptor reaction. J. Gen. Physiol. 69:1977;497.
13. Hiraoka M., Sunami A., Tajima K. Bisaramil, a new class I antiarrhythmic agent. Cardiovasc. Drug Rev. 11:1993;516.
14. Hodgkin A.L., Huxley A.F. A quantitative description of membrane current and its application to conduction and excitation in nerve. J. Physiol. (London). 117:1952;500.
15. + channels. Biochim. Biophys. Acta. 472:1977;373.
16. + and calcium channel-blocking drugs. Annu. Rev. Pharmacol. Toxicol. 24:1984;387.
17. + channel. Science. 256:1992;839.
18. Janse M.J. To prolong refractoriness or to delay conduction (or both)? Eur. Heart J. 13(Supplement F):1992;14.
19. + channel characteristic of denervated and immature rat skeletal muscle. Neuron. 4:1990;233.
20. + channel. Mol. Pharmacol. 43:1993;635.
21. + channel phenotype for inactivation and lidocaine block. Jpn. Heart J. 37:1996;733.
22. + channels. Naunyn-Schmiedeberg's Arch. Pharmacol. 336:1987;224.
23. + channels. Eur. J. Pharmacol. 214:1992;191.
24. + channels from cloned cDNA. Nature. 322:1986;826.
25. + channels (hH1) are intrinsically more sensitive to block by lidocaine than are skeletal muscle (μ1) channels. J. Gen. Physiol. 106:1995;1193.
26. Paroczai M., Karpati E., Solti F. The effects of bisaramil on experimental arrhythmias. Pharmacol. Res. 22:1990;463.
27. Paroczai M., Roth E., Matos G., Temes G., Lantos J., Karpati E. Effects of bisaramil on coronary-occlusion-reperfusion injury and free-radical-induced reactions. Pharmacol. Res. 33:1996;327.
28. + currents in isolated cardiac myocytes by bisaramil. Br. J. Pharmacol. 114:1995;377.
29. + channel. Proc. Natl. Acad. Sci. USA. 92:1995;11839.
30. + channels by local anesthetics. Science. 265:1994;1724.
31. + channels. Proc. Natl. Acad. Sci. USA. 93:1996;9270.
32. + current in rat single ventricular cells. Circ. Res. 52:1983;557.
33. Strichartz G. Molecular mechanisms of nerve block by local anesthetics. Anesthesiology. 45:1976;421.
34. + channel gating in excitable cells. Annu. Rev. Neurosci. 10:1987;237.
35. + channels by a charged class I antiarrhythmic agent, bisaramil: possible interaction of the drug with a pre-open closed state. Eur. J. Pharmacol. 312:1996;245.
36. Sunami A., Sawanobori T., Adaniya H., Hiraoka M. Electrophysiological properties of a new antiarrhythmic agent, bisaramil on guinea-pig, rabbit and canine cardiac preparations. Naunyn-Schmiedeberg's Arch. Pharmacol. 344:1991;323.
37. + channel. Neuron. 3:1989;33.
38. Vaughan Williams E.M. A classification of antiarrhythmic actions reassessed after a decade of new drugs. J. Clin. Pharmacol. 24:1984;129.
39. + channel subtypes. Biophys. J. 70:1996;1700.